Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Mipsagargin Demonstrates Clinical Benefit In Subset Of Glioblastoma Patients

 

Mipsagargin Demonstrates Clinical Benefit In Subset Of Glioblastoma Patients

2015-12-02 02:02:20| drugdiscoveryonline Home Page

GenSpera Inc., a biotech company developing a novel prodrug therapeutic for the treatment of cancer, recently announced results from the Phase II study investigating the use of mipsagargin (G-202) for the treatment of glioblastoma multiforme

Tags: benefit patients clinical demonstrates

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

09.05 Demand, crop prospects, global geopolitics: What's ahead? 09.05 Scalstrm and EZDRM partner on video content security 09.05 Appvion launches EarthChem sustainable direct thermal portfolio 09.05 Glatfelter Reports Financial Results 09.05 Maryland Adopts PaintCare Program 09.05 Society of Cosmetic Chemists Intermountain West to Host Healthy Bite Oral Care Symposium 09.05 A.Celli and Akinal Tekstil Collaborate on Line Installation 09.05 Record levels of shoplifting show signs of falling More »